OmniSeq News

OmniSeq Names Dr. Shengle Zhang as New Lab Director

FOR IMMEDIATE RELEASE MEDIA CONTACT: Sawyer Lipari Lambert & Co. 313.309.9551 slipari@lambert.com OmniSeq Names Dr. Shengle Zhang as New Lab Director Fast-growing cancer diagnostic laboratory continues focus on development of innovative product breakthroughs...

Schoenborn named CEO at OmniSeq

June 26, 2019 Buffalo News - OmniSeq Inc., a molecular diagnostic laboratory on the Buffalo Niagara Medical Campus, has a new CEO. Margot P. Schoenborn, formerly the company's chief administrative officer, has been promoted to the position.

People in the News

June 26, 2019 GenomeWeb - OmniSeq announced today that it has appointed Margot Schoenborn to succeed Mark Gardner as the firm's CEO.

Margot Schoenborn becomes CEO of fast-growing OmniSeq

Business First - Margot Schoenborn has quite the resume. Now she gets to add yet another interesting professional experience: biotech boss. Schoenborn has been named the CEO of OmniSeq, which develops and sells molecular diagnostic tests that show cancer patients what...

OmniSeq & LabCorp Launch OmniSeq Advance℠ Assay

New test combines both targeted therapy and immune-oncology biomarkers in a single test with 99% actionability, providing benefits for the treatment of patients and the development of new therapies.ASCO, CHICAGO, ILLINOIS – June 1, 2018 – OmniSeq® , a CAP accredited,...

Follow Us on Twitter

https://tinyurl.com/c2pjh9zm
In case you missed it, you can now view the ASCO 2021 by Dr. Robert Phillips, “Reimagining Precision Medicine Throughout a Patient’s Journey” highlighting @OmniSeq INSIGHT.
@Labcorp @LabcorpDrugDev
#PrecisionMedicine

Learn how @OmniSeq utilizes tumor immunogenic profiles to describe immune tumor microenvironments in multiple tumor types and to help predict clinical benefit from immune checkpoint inhibitors (ICIs) https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00308-6
#oncology
#precisionmedicine

Our work on integrating tumor inflammation and proliferation biomarkers in solid tumors is out. Read more here: https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00308-6
@OmniSeq #cancerresearch #immunotherapy #immunooncology #oncology #oncologyresearch #oncologyclinicalresearch

Sarbajit Mukherjee, MD, MS, shared his findings on the link between inflammation, immunotherapy and outcomes, while his mentee, Lei Deng, MD, shared his findings on the patients most likely to benefit from chemo after surgery.

In case you you missed it!!! Laboratory Corporation of America and OmniSeq have launched the OmniSeq INSIGHT genomic and immune profiling test.
https://tinyurl.com/nmm8a4rr

@GenomeWeb
@Labcorp
#precisionmedicine
#oncology

Load More...